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Abstract Biodentine is a tricalcium silicate-based material designed as a permanent dentin
substitute. It is biocompatible and bioactive material. Its interactions with both hard and soft
tissues lead to a marginal sealing preventing marginal leakage and provide protection to the
underlying pulp by inducing tertiary dentin synthesis. Unlike other dentin substitutes, Biodentine
application does not require any conditioning of the dentin surface and the restoration sealing is
provided by micromechanical retention as Biodentine penetrates into the dentin tubules forming
tag-like structures. After setting, Biodentine can be cut and reshaped like natural dentin. It can
also be bonded with different types of adhesives before finishing the final restoration with
composite resin. Published clinical trials, histology of human teeth and clinical cases show that
Biodentine has a wide spectrum of clinical applications as a permanent bulk dentin substitute in
endodontics, in restorative dentistry, and pediatric dentistry as a possible replacement material
of formecresol. This review brings a comprehensive understanding of Biodentine composition,
preparation properties and the mechanism of interactions with hard and soft tissues. It explains
the scientific mechanisms of the induction of these specific functions and illustrates the scientific
basis beyond their clinical successful use. The article provides an overview of Biodentine clinical
applications summarizing published clinical trials and reporting published clinical cases with this
material in restorative and pediatric dentistry as well as in endodontics.
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Riassunto Biodentine e` un materiale a base di silicato tricalcico progettato come sostituto
permanente della dentina. Si tratta di un materiale biocompatibile e bioattivo. Le sue interazioni
con entrambi i tessuti duri e molli portano ad una sigillatura marginale in grado di prevenire
l’infiltrazione marginale e forniscono una protezione alla polpa sottostante inducendo sintesi
dentina terziaria. A differenza di altri sostituti della dentina, l’applicazione di Biodentine non
richiede alcun condizionamento della superficie dentinale e la tenuta della restaurazione e`
fornito dalla ritenzione micromeccanica in quanto Biodentine penetra nei tubuli dentinali
formando strutture di simili ai resin-tag. Dopo l’indurimento, il Biodentine puo` essere tagliato
e rimodellato come dentina naturale. Puo` anche essere trattato con diversi tipi di adesivi prima di
terminare il restauro definitivo. Studi clinici pubblicati, istologia di denti umani estratti e casi
clinici dimostrano che Biodentine ha un ampio spettro di applicazioni cliniche, come sostituto
permanente della dentina in endodonzia, in odontoiatria restaurativa e odontoiatria pediatrica.
Questa review si propone di descrivere in maniera completa la composizione di Biodentine, le
proprieta` di preparazione e il meccanismo di interazione con i tessuti duri e molli. Essa spiega i
meccanismi scientifici che caratterizzano queste funzioni specifiche e illustra la base scientifica
del suo successo nell’utilizzo clinico. L’articolo fornisce inoltre una panoramica delle applicazioni
cliniche di Biodentine riassumendo gli studi clinici e riportando i casi clinici pubblicati con questo
materiale in odontoiatria restaurativa e pediatrica, cosı` come in endodonzia.
 2016 Societa` Italiana di Endodonzia. Production and hosting by Elsevier B.V. Cet article est
publie´ en Open Access sous licence CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-
nd/4.0/)
82 I. AboutTable 1 Biodentine composition: two components: liquid
and powder to be mixed with an amalgamator for 30 s at
4000 rpm.9
Powder Role
Tri-calcium silicate (C3S) Main core material
Di-calcium silicate (C2S) Second core material
Calcium carbonate and oxide Filler
Iron oxyde Shade
Zirconium oxyde Radio-opacifier
Liquid
Calcium chloride Setting accelerator
Hydrosoluble polymer Water reducing agentIntroduction
Over the past decades, search on restorative materials
focused on replacing amalgams in small anterior restorations
and on posterior restorations of moderate size by direct
composite restorations. Opposed to amalgams, a micro-
mechanical retention of resin composites can be achieved
with these materials by applying different adhesives. How-
ever, some drawbacks have been reported with resin-based
materials such as wear resistance under high stress, shrink-
age upon polymerization leading to microleakage and toxic
monomers release.1,2 In order to protect the pulp from resin-
based materials toxic components, Calcium hydroxide-based
materials have been widely used in direct pulp capping
procedures. In spite of a highly alkaline pH of this material,
a dentin bridge can form within 3 months providing a protec-
tion to the underlying pulp with mild or moderate inflamma-
tion. However, several studies demonstrated a partial
dissolution and that this bridge has tunnel defects.3,4 The
recent focus on biocompatible materials such as Portland led
to the development of Mineral trioxide aggregate (MTA) as a
root-end filling material and direct pulp capping. This mate-
rial is mainly composed of tricalcium and dicalcium silicates.5
When applied for pulp capping, it induces reparative dentin
production leading to a regular tubular dentin bridge forma-
tion within 2 months with no signs of inflammation.4 How-
ever, some shortcomings have been reported with this
material. These are related to its long setting time of 2 h
45 min, weak mechanical properties and difficult handling
properties.6 Additionally, tooth discoloration has been
reported when this material is used for revascularization.7,8
Biodentine is a recently released tricalcium silicate-based
material developed as a permanent dentin substitute to
replace the damaged dentin.9
In this review, the material composition, preparation
method and application, mechanical and physical properties
will be described, its interactions with the soft and harddental tissues will be explained and finally, Biodentine clin-
ical applications based on published works will be reported.
Biodentine composition
Biodentine is a two components material. The powder is
mainly composed of Tricalcium silicates. It also contains Di-
Calcium Silicate as a second core material and Calcium
Carbonate and Oxide as filler. The powder contains Zirco-
nium oxide as a radio-opacifier. The liquid contains Calcium
Chloride as a setting accelerator and a water reducing agent
(Table 1). The presence of a setting accelerator allows the
material setting in 12 min and the presence of a water
reducing agent avoids the formation of cracks within the
material. Such cracks are usually observed after setting of
cements containing high percentage of water.9 The material
is prepared by adding 5 drops of liquid to the powder present
in the capsule. These components are then triturated with
an amalgamator for 30 s at 4000 rpm leading to the forma-
tion of a paste of creamy consistency. The preparation
method and proportions between powder and liquid should
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instructions as these proportions greatly influence the mate-
rial’s setting and mechanical properties. This is of particular
significance mainly for applications under mechanical loads
such as applications in Class II cavities.
The setting reaction is a hydration reaction
When Biodentine powder and liquid are mixed with an amal-
gamator, the setting of the material is a hydration reaction.
While Calcium silicates partially dissolve by adding the liquid,
a hydrogel of hydrated silicate is produced. This will pre-
cipitate on the remaining Silicate particles’ surface and in the
spaces between the particles leading to a significant
decrease in the material’s porosity and an increase in its
compressive strength over time.9
Biocompatibility
Like any other restorative material, Biodentine Biocompat-
ibility was investigated to ensure its safety when applied onto
the cells. Evaluation of its genotoxicity on bacteria strains by
the Ames test and its effects on the formation of micronuclei
by human lymphocytes demonstrated the absence of any
mutagenic effect of the material. Similarly, when tested
on target human pulp cells, no DNA breaks or damage was
observed with the Comet assay. These results demonstrated
no genotoxic effects of Biodentine in vitro. The biocompat-
ibility of the material was also investigated through its direct
application to human pulp cells simulating the direct pulp
condition and indirectly through a dentin slice to simulate its
indirect pulp capping in vivo. Under both conditions Bioden-
tine was not found to affect target cell viability under in vivo
application conditions.9 Additionally, when Biodentine was
applied onto human pulp cells to investigate its effects on
their specific functions by studying expression of odontoblast
specific functions such as expression of Nestin (a human
odontoblast specific marker) and Dentin Sialoprotein, Bio-
dentine was not found to inhibit the expression of these
proteins but rather induce their expression and the cells
mineralization capacity.9—11 Further investigations demon-
strated the absence of toxicity of Biodentine to human MG63
human osteoblast cells with the MTT assay with properties
comparable to that of MTA.12
Interactions with hard tissues: no surface
preparation is needed to apply BiodentineTM
Clinical application of Biodentine in restorative dentistry
implies an intimate interaction with hard and soft tissues
as well as with other restorative materials. This should lead
to a marginal sealing in vivo which provides pulp protection
and marginal sealing. Thus investigating these properties in
ex vivo is of prime importance.
An experimental work using third molar teeth was used to
investigate the marginal sealing of Biodentine alone or in
combination of other resin-based materials using the silver
nitrate penetration method in Class II cavities. No marginal
leakage was observed at the Biodentin/dentin interface or at
the enamel/Biodentine interface when the whole cavity was
filled with Biodentine alone as a bulk restorative materialreplacing dentin and enamel without any conditioning treat-
ment. No leakage was observed when Biodentine surface was
prepared with the total etch technique and resin composite
application. The results of this investigation demonstrated
that the results obtained with Biodentine were similar to
those obtained with resin-modified glass ionomer cement
(Fuji II LC) considered as a reference material in this type
of indications.13 An interesting study compared the shear
bond strengths of different adhesive systems to Biodentine.
Adhesive systems such as Prime & Bond NT: etch-and-rinse
adhesive system, Clearfil SE Bond: 2-step self-etch adhesive
system and Clearfil S3 Bond: 1-step self-etch adhesive system
were applied onto Biodentine discs for 12 min and 24 h then a
Composite (Clearfil Majesty) was applied. Data showed that
the shear bond strengths were the same for different adhe-
sive systems to Biodentine.14 This confirms that the marginal
sealing of Biodentine is equivalent to that of RMGIC (Fuji II
LC) and that Biodentine can be etched and treated like
natural dentin. Different restorative materials can be suc-
cessfully applied on top of Biodentine. Whatever the surface
treatment used on Biodentine, this material can be used in
combination with composite resins.13,14
Biodentine interacts with hard tissues by
micromechanical retention
Interactions of Biodentine with the dentin provided cues to
understanding how this material provides a marginal sealing
without any dentin surface preparation: no etching and no
bonding. In an experimental work performed ex vivo, dentin
slices were prepared and Biodentine was prepared and mixed
with a fluorescent dye before its application onto the dentin
surface. Confocal laser scanning electron microscopy and
scanning electron microscopy were used to study the inter-
face between Biodentine and dentin. Confocal laser scanning
electron microscopy revealed that Biodentine penetrated
into the dentin tubules forming tag-like structures into the
dentin tubules. Scanning electron microscopy revealed that
the dentin tubules appeared with plugs of mineralization
crystals just beneath the interface obliterating the dentin
tubules. These results explain the micromechanical reten-
tion of the material on the one side and the marginal sealing
on the other side.15
Bioactive properties in vitro
An entire human tooth culture model was used to investigate
both the material hydration when placed for pulp capping
and its effects on the pulp response. The tooth culture model
provides a useful tool to investigate the initial steps of
dentin-pulp regeneration and the consequence of applying
pulp capping materials. Since the teeth used are immature
impacted third molars, they also have the advantage of a high
regeneration potential and not to be in contact with the oral
flora. Biodentine was applied into pulp cavities then an
adhesive resin was applied onto Biodentine and overlayed
with a composite resin. Hydration was allowed to proceed
under conditions similar to those in vivo by incubating teeth
in culture medium. After 14 days, back-scatter scanning
electron micrographs revealed that the material was homo-
genous and appeared completely hydrated at all areas
Figure 1 Biodentine direct application onto human pulp in human entire tooth culture for 4 weeks. Biodentine induced odontoblastic
differentiation and reparative dentin secretion. Mineralization foci containing sequestered cells are observed in the dental pulp
beneath Biodentine. The sequestered cells express odontoblast markers such as Dentin Sialoprotein (DSP) and nestin.10
84 I. Aboutexamined: within the material, at the Biodentine/dentin
interface, at Biodentine/composite resin interface and at
the Biodentine/pulp interface. The hydration of this type of
materials leads to the release of Calcium ions which are
necessary for the mineralization. X-ray diffraction analysis
of the material after setting demonstrated a significant peak
of Calcium hydroxide formation which has long been used for
pulp capping with a well demonstrated ability to induce
dentin bridge formation.16
This culture model provided valuable information on the
response to Biodentine application directly onto the pulp.Figure 2 Effect of Biodentine on TGF-b1 release from human
pulp cells. Biodentine induces release of TGF-b1 from human
pulp cells. *Significant as compared to the control.10Indeed, after application of Biodentine and culture for
14 days, mineralized structures appeared in the form of foci
in close vicinity of the material. This mineralization seemed
to be directly linked to Biodentine as some cement particles
were seen within the mineralized structures but not in the
neighboring pulp tissue. This mineralized tissue corresponds
to an early form of reparative dentin as cells sequestered
within these mineralizations express odontoblastic markers
such as nestin and dentin sialoprotein (Fig. 1).
This mineralization seems to be due to the release of a
growth factor, namely Transforming factor beta 1 (TGF-b1)
from pulp cells incubated with Biodentine (Fig. 2). This factor
has been shown to be involved in odontoblastic differentia-
tion and recent investigations revealed that this factor is
involved in the recruitment of pulp stem cells to TGF-b1pro-
duction site17 which is related to Biodentine application.
Interestingly, increase in TGF-b1 was significant whatever
the ratio between the Biodentine surface area and cell
culture volume.10 This has a clinical significance as it indi-
cates that this cement can be applied onto the pulp whatever
the injured pulp surface area (Fig. 2).
Biodentine interactions with soft tissues
induce tertiary dentin synthesis
When Biodentine was used for vital pulp therapy in vivo,
investigations carrier out on different animal models showed
Biodentine bioactive properties 85that this material can be applied for both pulp capping and
pulpotomy. Indeed, Biodentine induced tertiary dentin
synthesis when applied as direct or indirect pulp capping
material in rat teeth.18,19 After direct pulp capping, the
dentin bridge observed after 4 weeks in rat teeth was tubular
and its porosity was similar to that of MTA.19 Similar results
demonstrated in miniature swine teeth. Indeed, after pulp
capping with Biodentine, no pulp inflammation was observed
while a thick dentin bridge formed after 3 and 8 weeks.20
Similar results were reported in primary pig teeth after
4 weeks and 90 days. Application of Biodentine in pulpotomy
was also investigated in primary pig teeth and compared to
formecresol and white MTA (WMTA). The results with Bio-
dentine showed no inflammation and a thick dentin bridge
formed in 90% of the cases.21 These data were comparable to
the results obtained with WMTA and indicate the biocompat-
ibility of these materials and their suitability for pulp capping
and pulpotomy.
Clinical applications
Although Biodentine is a recently developed material as it has
been released by the end of the year 2010 in Europe,
different clinical applications have been so far published
with this material. These include applications in restorative
dentistry, pediatric dentistry and endodontics. Although it
can be used as a temporary enamel substitute for upto
6 months, Biodentine is mainly used as a permanent dentin
substitute. It can be used to replace the missing/damaged
bulk dentin volume. It can also be used as an alternative toTable 2 Biodentine clinical applications and type of clinical
works published on each application. Biodentine can be used
in restorative dentistry, pediatric dentistry and endodontics
as a permanent dentin substitute. It can be used to replace
the missing/damaged whole dentin volume. It can also be
used as an alternative to formecresol in pulpotomy.
Application Type of investigations/
references
Crown
Temporary enamel restoration Clinical trials 22
Permanent dentin substitute in
Deep/large carious lesions Clinical trials 22
Deep cervical/radicular lesions Case reports36—38
Indirect pulp capping Clinical trials22,23
Direct pulp capping Clinical and
histological studies25,26
Pulpotomy Clinical trials27,39
Root
Root canal/furcation
perforations
Case reports 40
External resorption Case reports 41
Internal resorption Case reports 42
Regenerative endodontics Case reports 43
Apexogenesis after traumatic
exposure
Case reports33,44
Apexification Case reports45—48
Retrograde root canal
obturation
Case reports49,50Formecresol in pulpotomy. The major clinical trials and
histological studies in human teeth are detailed below and
reported (Table 2) while the clinical case reports are only
listed in the same table.
Indirect pulp capping
A randomized clinical study was performed in the restoration
of posterior teeth with Biodentine. 397 cases were included
with a three years follow-up. Biodentine was applied as a bulk
restorative material in deep dentin cavities in replacement
of both dentin and enamel. The scoring scales included
consistency, working time, adhesion to instruments, ease
of handling, anatomic form, marginal adaption, quality of
proximal contact, marginal discoloration, surface roughness,
secondary caries and post-operative pain. The results of this
trial reported that Biodentine was easy to handle, showed, a,
excellent anatomic form, marginal adaptation and very good
interproximal contact. During the follow-up, the restoration
with BiodentineTM in comparison to the composite resin Z100
was well tolerated in all cases with no post-operative pain.
The anatomic form, marginal adaptation and interproximal
contact started to deteriorate only after 6 months. Due to the
deterioration, a complementary treatment was performed.
Biodentine was kept as dentin substitute as the pulp vitality
test was positive. Biodentine presented a good resistance to
burring and the composite Z100 was applied onto Biodentine
surface and evaluated for up to 3 years. The conclusions of
this study is that Biodentine can be used as a posterior
restoration material for up to 6 months as a temporary
enamel substitute. When covered with Z1001, it is a well-
tolerated permanent dentin substitute. Additionally, Bioden-
tine can be cut and shaped like the natural dentin.22 In
another clinical study, the efficacy of Biodentine as an indir-
ect pulp capping material was evaluated and compared to a
glass ionomer cement (Fuji IX) in irreversible pulpitis. 36
restorations with Biodentine and 36 Fuji IX were placed
randomly in 53 patients. The clinical efficacy at 12 months
revealed no statistically significant differences in clinical
efficacy between Biodentine and Fuji IX.23
The reported absence of post-operative pain and post-
operative sensitivity in the clinical trial22 may be due at least
to 2 factors:
1) The infiltration of Biodentine into the dentin tubules15 due
to the precipitation of crystals within the tubules
decreases the dentin tubule permeability and fluid move-
ment which may decrease post-operative sensitivity.
2) The reduction odontoblast pain receptor expression and
function and the reduction of the secretion of pro-inflam-
matory cytokines. Indeed, odontoblasts express pain
receptors of the transient receptor potential family of
ion channels (TRP) namely TRPA1. These receptors play a
significant role in nociception and neurogenic inflamma-
tion. When extracts of Biodentine were applied on odon-
toblast-like cells, expression of these receptors decreased
together with their functional activity as measured by an
intracellular calcium level increase. Additionally, Applica-
tion of Biodentine decreased the pro-inflammatory tumor
necrosis factor secretion (TNF-a) from odontoblast like
cells24 as measured by Enzyme-linked immunosorbent
assay (ELISA).
I. AboutDirect pulp capping
Pulps of 28 non-carious molars scheduled for orthodontic
treatment were exposed mechanically and pulps capped
directly with Biodentine or MTA in class I cavities. 7 patients
complained from mild pain on the day of surgery. 4 of these
patients were treated with Biodentine and 3 with MTA. No
symptoms were reported in the other patients. Teeth were
tested before extraction for cold and electro-sensitivity and
all confirmed the pulp vitality. The absence of periapical
pathology was confirmed radiographically before the treat-
ment and just before the tooth extraction. The histological
examination of the pulp state and response after direct pulp
capping with Biodentine as compared to MTA in human teeth
revealed an absence of pulp inflammation and the formation
of a complete dentin bridge beneath both materials after
6 weeks.25 Tomographic data evaluating the density and
volume of reparative dentin revealed that these values were
higher for Biodentine.26 These results indicate that Bioden-
tine can be safely applied directly onto the human vital pulp.
Pulpotomy
Clinical application of Biodentine in pulpotomy has been
investigated in few clinical studies as a pulpotomy medica-
ment. A randomized clinical study was performed in children
of 4—9 years of age. 84 pulpotomies were performed and
attributed to MTA or Biodentine. All teeth were restored with
stainless steel crowns. Clinical and radiographic evaluations
were performed after 6 and 12 months. Data showed that one
molar of the MTA group had an internal resorption while 1
molar of Biodentine treated group had internal resorption
and another showed a radiographic radiolucency. Over all,
both materials had a very high clinical success rate27 and the
overall clinical success after 12 months is reported (Table 3).
Another study evaluated Biodentine and compared it to MTA
in a short term clinical study. Biodentine was applied in
pulpotomy in 20 teeth followed by restoration with stainless
steel crowns. At 3 and 6 months, patients were recalled
and Biodentine was shown as equally efficient as MTA with
similar radiographic success.28 A similar study was performed
comparing Biodentine to MTA and Propolis as pulpotomy
medicaments. After 9 months, Biodentine and MTA showed
comparable results with a high radiographic success rate and
more favorable than Propolis.29 Finally, a confirmation of all
these data reported no significant differences between MTA
and Biodentine used as pulpotomy medicaments even after
18 months with clinical success higher than 95% for both
materials.30 Taken together, although longer term clinical
evaluations are required, these data indicate that Biodentine
86 Table 3 Evaluation of Biodentine as compared to MTA in
pulpotomy after 12 months. Clinical success rates are
reported in number of cases and percentage showing a high
clinical success rate of both MTA and Biodentine in pulpotomy
after 12 months.27
Success/total number of cases Success (%)
MTA 36/39 92
Biodentine 38/39 97has the potential to be used as a substitute for formocresol in
primary molar pulpotomies.
Case reports on the other clinical
applications
In addition to the above detailed indications, many case
reports have been published with Biodentine in different
clinical indications. These include deep cervical/radicular
lesions, root canal/furcation perforations, external/internal
resorption, regenerative endodontics, apexogenesis after
traumatic exposure, apexification and retrograde root canal
obturation. These applications are listed and corresponding
case report references are provided (Table 2).
Discussion
Although Biodentine is among the most recently developed
tricalcium silicate-based materials, a significant and increas-
ing number of investigations have been published on this
material. While many studies reported its biocompatibility
and Bioactivity in vitro and in vivo, preclinical investigations
shed the light on the mechanisms of its interaction with the
dental hard tissue. Indeed, many investigations performed
both in vitro and in vivo demonstrated that the interactions
of Biodentine with both hard and soft tissues provide a
hermetic seal protecting the dental pulp by preventing
bacterial infiltration. These studies demonstrated that,
through its interactions with the hard tissues, Biodentine
provides a micro-mechanical retention by infiltrating the
dentin tubules. On the other hand it induces the target
tissue specific functions by inducing tertiary dentin synthesis
which provides further protection to the pulp. These two
combined effects might be responsible, at least in part, for
the absence of post-operative pain and hypersensitivity.
Another important investigation reported that the applica-
tion of Biodentine reduces both TRPA1 pain receptor expres-
sion and function. More importantly, when applied on
odontoblast-like cells Biodentine decreases pro-inflamma-
tory TNF-a secretion. This indicates that, in addition to
the abovementioned roles of Biodentine, its application onto
the dentin/pulp reduces the inflammation and consequently
the post-operative pain.
How does Biodentine compare to other
widely used and common pulp capping
materials
When compared to Calcium Hydroxide, Biodentine is stronger
mechanically due to its composition and low porosity. It is less
soluble and the produced dentin bridge shows no tunnel
defects as compared to that under Calcium hydroxide thus
it has a better sealing ability than Calcium hydroxide.19,31
When Compared to MTA, Biodentine is easier to handle,22
stronger mechanically and has a shorter setting time.6 It can
be used as a temporary enamel substitute up to 6 months and
in different applications as a permanent dentin substitute
without any surface treatment. Additionally, while discolora-
tion with MTA32 and its derivatives have been reported in
regenerative endodontics and seem to be mainly due to the
Biodentine bioactive properties 87presence of Bismuth oxide as a radio-opacifier,7 no discolora-
tion of tooth crown has been reported after 48 months
with Biodentine which does not contain Bismuth oxide but
Zirconium oxide as a radio-opacifier.33—35
Conclusions
Taken together, through in vitro, in vivo, clinical trials/
reports, this review shows that Biodentine is biocompatible,
has strong mechanical properties and can safely be applied in
restorative dentistry, in pediatric dentistry (as a possible
alternative to formecresol) and in endodontics. It is impor-
tant to know that Biodentine does not require any surface
conditioning treatment. It can be cut and reshaped like
natural dentin. It can be used as a bulk permanent dentin
substitute to replace the whole damaged/lost dentin and not
only as a pulp capping material. Biodentine surface can be
bonded like the natural dentin with different adhesives
before final composite resins application.
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